📰 Avidity Analyzer News

Avidity Analyzer News Today

Fast, Ad-Free News Updates

Stay updated with breaking news from Avidity Analyzer. Real-time updates on events, politics, business and more.

LUMICKS: Cancer Cell Paper Identifies Avidity Enhancement As New Strategy for Improving CAR T Therapy for Acute Myeloid Leukemia

May 24, 2022

Research Revealed Through Cell Avidity Measurement Demonstrates Superior Tumor Clearance In Vivo Due To "Avidity Enhancement" AMSTERDAM, May 24, 2022 /PRNewswire/ -- LUMICKS, a leading

United States Noord Holland Paul Wheeler Marcelav Maus Andrea Candelli Maus Lab

Source: finanznachrichten.de

LUMICKS Appoints Andre Nel as Chief Financial Officer

May 9, 2022

Life Sciences Finance Veteran To Help Company Scale Globally AMSTERDAM, May 9, 2022 /PRNewswire/ -- LUMICKS, a leading life science tools company that develops instruments for dynamic single-molecule

South Africa United Kingdom Noord Holland Russian Federation Kostenloser Wertpapierhandel Joshua Young

Source: finanznachrichten.de

New Customer Installation of LUMICKS' z-Movi Cell Avidity Analyzer Confirms Value of Cell Avidity Measurement in Leading Labs Studying Biomarkers of Immune Oncology

April 21, 2022

New Customer Represents Leading-Edge Scientific Research AMSTERDAM, April 21, 2022 /PRNewswire/ -- LUMICKS, a leading life science tools company that develops instruments for dynamic single-molecule

Noord Holland Kassandra Barbetsea Dirk Busch Elvira Dippolito Technical University Of Munich School Of Medicine

Source: finanznachrichten.de

LUMICKS Strengthens its Innovative C-Trap Solution with Launch of New Lakeview Analysis Software Platform

April 5, 2022

Lakeview software enables easier data analysis, solidifying the end-to-end C-Trap solution for dynamic single-molecule analysis, and democratizing use by researchers AMSTERDAM, April 5

United States Noord Holland Jos Maas Kassandra Barbetsea Experimental Biology General Manager

Source: finanznachrichten.de

LUMICKS: Frontiers in Immunology Paper Discloses Promising New Insights into CAR T Cell Efficacy for Cancer Therapies

March 17, 2022

AMSTERDAM, March 17, 2022 /PRNewswire/ -- LUMICKS, a leading life science tools company that develops instruments for dynamic single-molecule and cell avidity analysis, today announced that

City Of United Kingdom Noord Holland John Maher Andrea Candelli Kassandra Barbetsea

Source: finanznachrichten.de

Stay Updated with Latest News

Get breaking news updates delivered to your inbox

Browse All News →

LUMICKS Unveils Groundbreaking New C-Trap Product at Biophysical Society Annual Meeting

February 22, 2022

New product line C-Trap 'Edge' brings unparalleled features relevant for surface assays, which are of increasing importance in biophysical and biological research AMSTERDAM, Feb. 22, 2022

United States San Francisco Noord Holland Jos Maas Kostenloser Wertpapierhandel Joshua Young

Source: finanznachrichten.de

New Nature Paper Relies on LUMICKS' C-Trap Technology to Understand Functionality of Key Protein Involved with Incorrect DNA Repair of Dangerous Lesions Linked to Cancer Predisposition

February 15, 2022

AMSTERDAM, Feb. 15, 2022 /PRNewswire/ -- LUMICKS, a leading life science tools company that develops equipment for dynamic single-molecule and cell avidity analysis, today announced that its

New York United States City Of United Kingdom Noord Holland Simonj Boulton

Source: finanznachrichten.de

LUMICKS: New study published in Translational Medicine highlights cell avidity's power as a functional biomarker for improved CAR-T design in preventing tumor escape

January 25, 2022

AMSTERDAM, Jan. 25, 2022 /PRNewswire/ -- LUMICKS, a next generation life science tools company, today announced that research findings from a consortium, led by researchers at Cancer Center

Noord Holland Kostenloser Wertpapierhandel Joshua Young Maria Themeli Andrea Candelli Kassandra Barbetsea

Source: finanznachrichten.de

LUMICKS Raises $93 Million in Series D Financing

April 16, 2021

LUMICKS Raises $93 Million in Series D Financing - Backed by global investor syndicate led by new investors Farallon Capital Management and Lauxera Capital Partners along with Softbank Fund 2, funds and accounts advised by T. Rowe Price Associates, Parian Global Management, Gilde Healthcare, Pura Vida Investments, and Irving Investors AMSTERDAM, April 16, 2021 /PRNewswire/ -- LUMICKS, a leading, next-generation life science tools company that develops highly innovative platforms for Dynamic Sin...

France General San Francisco United States Noord Holland Kostenloser Wertpapierhandel Erwin Peterman

Source: finanznachrichten.de

Explore More Categories

World News India News Business Technology Sports Entertainment Health Science

Navigation

Avidity Analyzer News Today

Stay Updated with Latest News

Explore More Categories